Condition: Basal Cell Carcinoma · Cutaneous Squamous Cell Carcinoma · Sponsor: EuMelaReg gGmbH
This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.
This description comes directly from the study's public registry record.
Alexandra Hansen · +493037026901 · alexandra.hansen@eumelareg.org
Always discuss trial participation with your own doctor first.
| UZ (Universitair Ziekenhuis) Brüssel | Brussels, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05741073